Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMS Activities Put Additional Burden on Doctors
October 5, 2009
- Price Gaps Remain Unchanged for Drugs Priced by Similar Efficacy Comparison Method
October 5, 2009
- Fixed-Dose Combination Drugs Should Be Priced at 10-30% of the Sum of Prices of Combined Drugs: Korosho
October 5, 2009
- Term of Office to Expire for 6 of 7 Chuikyo Members Representing Healthcare Providers
October 5, 2009
- Drug Wholesalers Should Compete on the Strength of Their General Capability: Mr Kinoshita
September 28, 2009
- Promotional Activities for Pariet Have Greatest Impact on Prescription: Survey
September 28, 2009
- Cravit Remains No. 1 on Both HP and GP Markets: Rep Track Survey
September 28, 2009
- Support from Drug Makers Influence Doctors Prescription
September 28, 2009
- BUSINESS NEWS IN BRIEF
September 28, 2009
- SEMINAR
September 28, 2009
- Fundamentally Review Budget Formation Process: Mr Hatoyama
September 28, 2009
- 24-Year-Old Woman without Underlying Disease Dies due to New-Type Flu
September 28, 2009
- METI to Support Drug Development Technology
September 28, 2009
- NEW PRODUCTS
September 28, 2009
- JPMA to Stress Importance of Pharma Industry to New Govt
September 28, 2009
- First Biosimilars Priced at 70% of Prices of Original Products
September 28, 2009
- REGULATORY NEWS IN BRIEF
September 28, 2009
- Sales of Ethical Drugs Up 5.3% in July: Crecon
September 28, 2009
- Akira Nagatsuma Appointed Health Minister
September 28, 2009
- Novo Nordisk to Develop Worlds First Oral GLP-1 Analogue, Insulin
September 28, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…